Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 7Interventional 3

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1

Conditions

Neoplasms 2Urinary Bladder Neoplasms 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Disease 1Adenocarcinoma 1

Interventions

pembrolizumab 1258Specimen Handling 864Carboplatin 824Magnetic Resonance Spectroscopy 806Cyclophosphamide 798Cisplatin 719Nivolumab 660Paclitaxel 635Gemcitabine 570Radiotherapy 570Biopsy 526Bevacizumab 467Dexamethasone 441fludarabine 403Docetaxel 375venetoclax 369Oxaliplatin 363Capecitabine 355Fluorouracil 354atezolizumab 337Rituximab 333durvalumab 332Doxorubicin 316Pemetrexed 306Radiosurgery 304Drug Therapy 300Ipilimumab 296Standard of Care 288Etoposide 283Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Urine Specimen Collection × 1 year × Clear all
NCT02807129 2026-01-21

AgElOn

CHU de Reims

Phase NA Completed
296 enrolled
Tumor-Agnostic

Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

Centre Hospitalier Universitaire de la Guadeloupe

Phase NA Recruiting
3,000 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05151341 2025-07-24

URODX-FGFR3

Institut de Cancérologie de Lorraine

Phase NA Completed
190 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡